SAVE 10% OFF First Order With Coupon Code: BetteryouRX10
Original price was: $78.00.$50.00Current price is: $50.00.
The Evra patch releases a steady dose of norelgestromin and ethinyl estradiol into the bloodstream. These hormones prevent ovulation (the release of an egg from an ovary) and cause changes in the cervical mucus and endometrial lining, making it harder for sperm to reach the uterus and for a fertilized egg to attach to the uterus.
Evra is a transdermal patch used for hormonal contraception. It delivers a combination of norelgestromin, a progestin, and ethinyl estradiol, an estrogen, directly through the skin into the bloodstream. This method of contraception is designed for ease of use and is an effective alternative for those who may have difficulty with daily oral contraceptive pills.
| Usage | Indications: ● Evra is indicated for the prevention of pregnancy in women who choose to use a transdermal patch as their method of contraception. Application: ● Apply one patch per week for three weeks, followed by a patch-free week. Patients are advised to: ● Avoid consecutively applying the patch in the same location to minimize skin irritation. |
|---|---|
| Side Effects | ● Skin irritation at the application site More serious side effects that require immediate medical attention: ● Signs of a blood clot (sudden shortness of breath, chest pain, vision changes) |
| Storage | Evra patches should be stored at room temperature, between 15°C and 30°C (59°F and 86°F). The sachets should be kept sealed until use and stored in a location out of reach of children and pets. |
| Special Precautions | Patients should inform their healthcare provider if they have: ● A history of clotting disorders, heart disease, stroke, or hormone-sensitive cancer, as combined hormonal methods like Evra, can increase the risk of these conditions. Before initiating treatment, important disclosures include: ● If they are pregnant, planning to become pregnant, or breastfeeding – the patch is not recommended for these individuals. |
| Overdose | An overdose of Evra is unlikely to occur due to its transdermal application method. However, if multiple patches are applied or ingested, it might lead to symptoms of excessive hormonal exposure such as nausea, vomiting, and vaginal bleeding. In such instances, the patches should be removed, and medical attention should be sought. |
You must be logged in to post a review.
Reviews
There are no reviews yet.